Market Trends Bristol sBLA for Opdivo, Yervoy combination in colorectal cancer accepted by FDA (BMY:NYSE)By admin8996erT0allFebruary 24, 2025 hapabapa A sBLA submitted by Bristol Myers Squibb (NYSE:BMY) for a combination of Opdivo (nivolumab) + Yervoy (ipilimumab) for microsatellite…
